Ozempic-maker Novo Nordisk To Shake Up Board
Denmark's Novo Nordisk said Tuesday it would replace more than half of its board, including the chair, as the Ozempic and Wegovy maker restructures in the face of rising competition for its anti-obesity treatments.
International Business Times ·